Clinical Trials
All Clinical Trials - Page 12 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06352424Phase 1Completed
A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
Survodutide
- NCT06373146Phase 2Completed
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Tirzepatide
- NCT06173778Phase 2Recruiting
Semaglutide for Post-Smoking Cessation Weight Management
Semaglutide
- NCT06369610Phase 2Recruiting
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
Gonadorelin
- NCT06292065N/ACompleted
Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy
Semaglutide
- NCT06297616Phase 1Completed
A Study of LY3841136 in Japanese Participants With Obesity or Overweight
Tirzepatide
- NCT06354660Phase 3Completed
Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Retatrutide
- NCT06283641N/ACompleted
Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
Liraglutide
- NCT06235086Phase 3Completed
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
Dulaglutide
- NCT05822609Phase 2Recruiting
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Semaglutide
- NCT06345066Phase 1Completed
A Study of LY3841136 in Overweight and Obese Participants
Tirzepatide
- NCT06309992Phase 3Completed
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
Survodutide
- NCT06390501N/ACompleted
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
Semaglutide
- NCT06131372Phase 2Completed
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
Semaglutide
- NCT06552598Phase 1Recruiting
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Thymosin-Alpha-1
- NCT06346457N/AUnknown
Breast Cancer & Antiestrogenic Therapy & Brain
Gonadorelin
- NCT06339086Phase 3Unknown
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Semaglutide
- NCT07590219Phase 4Active Not Recruiting
Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity
Liraglutide
- NCT06323161Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Semaglutide
- NCT06313528Phase 1Completed
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
Retatrutide
- NCT06324461Phase 4Recruiting
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
Dulaglutide
- NCT06323174Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Semaglutide
- NCT06326060Phase 2Completed
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
Tirzepatide
- NCT06326047Phase 2Completed
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
Tirzepatide
- NCT06297603Phase 3Active Not Recruiting
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
Retatrutide
- NCT06299098Phase 2Active Not Recruiting
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
Semaglutide
- NCT06200467Phase 1Completed
A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
Survodutide
- NCT06301256N/AUnknown
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
Tirzepatide
- NCT06388642Phase 1/Phase 2Completed
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
Afamelanotide
- NCT06410352Phase 4Recruiting
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Semaglutide
- NCT06290453N/AUnknown
The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis
Follistatin
- NCT06184568Phase 3Completed
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Semaglutide
- NCT05827081Phase 3Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Gonadorelin
- NCT06289504Phase 1Completed
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Semaglutide
- NCT06161844Phase 3Completed
Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT06207877Phase 1Completed
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
Semaglutide
- NCT05424003Phase 2Recruiting
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Semaglutide
- NCT06260722Phase 3Active Not Recruiting
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Retatrutide
- NCT06234111N/AActive Not Recruiting
Semaglutide and Physical Activity for Obesity and Multimorbidity
Semaglutide
- NCT06267092Phase 1Completed
A Study of How CagriSema Works on Appetite in People With Excess Body Weight
Semaglutide
- NCT06901648Phase 2Completed
A Study of HS-20094 in Patients With T2DM
Dulaglutide
- NCT06214741Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
Survodutide
- NCT06243536Phase 4Unknown
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
Semaglutide
- NCT06132477Phase 4Recruiting
Impact GLP-1 Agonists Following Bariatric
Semaglutide
- NCT07128394N/ARecruiting
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
Gonadorelin
- NCT06072963Phase 2Recruiting
COMMETS- Combination MCI Metabolic Syndrome
Semaglutide
- NCT05965908Phase 3Completed
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
Liraglutide
- NCT05746039Phase 1/Phase 2Recruiting
Feasibility of Semaglutide in Advanced Lung Disease
Semaglutide
- NCT06171152EARLY_Phase 1Suspended
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Liraglutide
- NCT05896566Phase 2Completed
A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer
Sermorelin